Article
Towards optimising HIV-1 derived lentiviral vectors through structure informed genome modifications
2020-01-01
Abstract excerpt
Lentiviral vectors are being successfully used as therapeutic agents in a series of clinical applications of gene therapy, genome editing and cancer immunotherapy. 3rd generation HIV-1 derived lentiviral vectors are produced from 4 independent plasmids. Here, I focus on the transfer vector that contains the therapeutic gene and the cis-acting elements that drive its expression including the packaging signal (psi)....
Topics
Open a Topic to create a Post that cites this publication.
Identifiers and source
- Literature Corpus work
- 595aa02c-5de9-5784-b340-597ef3b266d6
- DOI
- 10.17863/cam.51498
